跳至主要内容
临床试验/NCT05162664
NCT05162664已完成不适用

Presence of Signs of Central Sensitization in Episodic and Chronic Migraine - a Cross Sectional Study

University Ghent2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2021年10月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
2
主要终点
Extend of Central sensitization by central sensitization inventory (CSI) as a scale

研究概览

简要总结

Nowadays migraine is conceptualized as a continuum, with at the one hand episodic migraine (EM) and at the other hand chronic migraine (CM) (1). The general aim of the study is to determine where exactly in this continuum central sensitization (CS) appears.

Recent studies support the presence of CS in migraine patients (2,3), but controversial evidence exists about where in the continuum exactly CS appears. Some studies determined no differences in sings of CS between EM and CM (4,5), whether other research indicate a clear difference between EM and CM (6-8). However a significant difference in CS parameters could be determined between a patient group (EM or CM) and a healthy control group (3,4,8). In addition, CS appears to be present during the migraine attack (2). In this research, the presence of signs of CS will be determined in between headache phases.

The primary outcome measure is identification of CS by PPT, QST, TS, CPM and CSI. Secondary outcome measures are the outcome of the MIDAS, HADS and EUROLIGHT.

详细描述

For objectifying central sensitization, both self-reported and psychophysiological measures of allodynia and hyperalgesia will be used. These symptoms are considered to be signs of central sensitization, especially when present at distant pain-free areas (9).

Therefore, 100 patients with migraine (50 EM, 50 CM) and 50 healthy controls will be recruited. The patients should meet the following inclusion criteria: 1) diagnosis of migraine headache based on the criteria of ICDH-3 and verified by a medical doctor, 2) not being pregnant or have given birth in the preceding year, 3) adults between the age of 18 years and 65 years. Exclusion criteria are: 1) any other diagnosis of headache or mixed form, 2) any structural neurological syndrome, 3) any neurological brain event in the past, 4) surgery at the head, neck or shoulder the last 3 years.

As thermal testing might be followed by a mechanical hyperalgesia (10), this protocol will start with evaluating the mechanical sensitivity and afterwards the thermal sensitivity. The mechanical sensitivity will be determined by measuring PPT (A). A standardized and reliable QST protocol (B), including detection and sensitivity to warmth and cold, will be used (11). The temporal summation (C) will be used to asses endogenous pain facilitating pathways and conditioned pain modulation (CPM) (D) will be used to assess the endogenous pain inhibitory pathways. In addition questionnaires (E) will be conducted. The patients will be tested unilateral at the painful side and interictally.

Pressure pain thresholds PPT will be performed firstly at the anterior tibial muscle halfway between the most superior attachment to the tibia and its tendon in the upper one third of the muscle belly (13) and secondly at the middle of the temporalis muscle (12), using a digital algometer (Wagner FPX 50) with a 1 cm2 rubber tip. The pressure algometer will apply a perpendicular increasing pressure (1kg/s) at the different test locations until the participant reports the first feeling of pain. The PPT of 4 series of ascending stimulus intensities, with an inter-stimulus interval (ISI) of 20sec between the different stimuli and an ISI of 60sec between the 2 locations, will be measured. The first stimulus is a familiarization stimulus. Afterwards the mean of the 3 subsequent stimuli will be calculated.

Thermal detection and pain thresholds The thermal tests will be performed unilateral at tibial anterior, thenar and the forehead, using a TSA-2 (Neuro Sensory Analyzer, MEDOC). At first cold and heat detection thresholds will be measured. The patient will be asked to indicate when they feel a change in temperature. Afterwards the patient will be asked to indicate when the stimulus becomes painful to determine the cold and heat pain thresholds. The thresholds of 4 series of stimuli will be measured. The first stimulus is a familiarization stimulus. Afterwards the mean of the 3 subsequent stimuli will be calculated for every location. The subject will push a button when the thresholds are reached. The baseline temperature will be 32°C and the stimuli will increase with 1°C/s (14). The contact area of the thermode will be 16mm x 16mm. The cut-off temperature for heat is 53°C and for cold 0°C. The ISI will be 20 seconds on one location, and 1min between different locations. After measuring a thermal detection threshold, the temperature will go back to baseline with 1°C/s and after a thermal pain threshold measurement with 5°C/s.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Factorial
主要目的
Basic Science
盲法
Single (Outcomes Assessor)

盲法说明

In total, three investigators are involved. One is in charge for the screening process, and is not blinded for the status of the participants. The second investigator, i.e. the outcome assessor, is blinded for the status of the participants, and performs the clinical assessments (NOT the questionnaires). A third senior researcher is supervising the process.

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Extend of Central sensitization by central sensitization inventory (CSI) as a scale

时间窗: at baseline

The primary outcome will include the score of each participant on the CSI questionnaire.

Extend of central sensitization by quantitative sensory testing (QST) in °C.

时间窗: at baseline

The primary outcome will include heat detection treshold and heat pain treshold.

次要结局

  • Extend of Disability measured by the MIDAS questionnaire.(at baseline)
  • Extend of Anxiety and depression measured by the HADS questionnaire.(at baseline)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Presence of Signs of Central Sensitization in... | 临床试验